The global demand for Digital Biomarkers Market is presumed to reach the market size of nearly USD 19.48 BN by 2030 from USD 3.6 BN in 2022 with a CAGR of 23.5% under the study period 2023 - 2030.
Digital biomarkers refer to measurable and quantifiable health-related data collected through digital devices and technologies, including wearables, smartphones, sensors, and other connected tools. These data points are used to monitor and analyze various aspects of an individual's health and behaviour in real time. These biomarkers provide valuable insights into a person's physiological, psychological, and behavioural patterns, enabling healthcare professionals and researchers to obtain a more holistic understanding of their well-being.
The Digital biomarkers market is experiencing robust growth due to a combination of factors propelling the integration of technology into healthcare. Advancements in wearable devices, remote monitoring, and data analytics enable the collection of real-time health data, forming the basis for digital biomarkers. These biomarkers facilitate personalized healthcare, preventive approaches, and early detection of health issues. The wide adoption of smartphones, coupled with an ageing population and rising chronic diseases, fuels the demand for remote monitoring solutions. These biomarkers also find utility in mental health monitoring and clinical trials, while regulatory support and consumer awareness further drive their adoption. Nonetheless, challenges like data privacy and accuracy necessitate attention. The convergence of technology, healthcare needs, and patient empowerment underpins the expanding Digital biomarkers market, revolutionizing healthcare delivery and research methodologies.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of digital biomarkers. The growth and trends of digital biomarkers industry provide a holistic approach to this study.
This section of the digital biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Clinical Practice
By Therapeutic Area
By End-Use
This section covers the regional outlook, which accentuates current and future demand for the Digital Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Biomarkers market include ActiGraph LLC, AliveCor Inc., Koneksa, Altoida Inc., Amgen Inc., Biogen Inc., Empatica Inc., Vivo Sense, IXICO plc, Adherium Limited, Neurotrack Technologies, Inc., Aural Analytic, Huma, Sonde Health, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . DIGITAL BIOMARKERS – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Clinical Practice
3.7.3 Market Attractiveness Analysis By Therapeutic Area
3.7.4 Market Attractiveness Analysis By End-Use
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Wearable Historic and Forecast Sales by Regions
5.5 Mobile Based Applications Historic and Forecast Sales by Regions
5.6 Sensors Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions
6 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE
6.1 Overview by Clinical Practice
6.2 Historical and Forecast Data
6.3 Analysis by Clinical Practice
& ...